Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John E Mendelson

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Biological Psychiatry|October 5, 2011
Is brain-derived neurotrophic factor a selective biomarker that predicts cocaine relapse outcomes?Jacqueline F McGinty, John E Mendelson
Nitric Oxide : Biology and Chemistry|July 13, 2007
Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction?Anousheh Kielstein, Dimitrios Tsikas, Gantt P Galloway, et al.
Journal of Addiction Medicine|August 17, 2011
A simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephonesGantt P Galloway, Jeremy R Coyle, José Enrique Guillén, et al.
Psychopharmacology|August 13, 2002
Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humansDebra S Harris, Matthew Baggott, Jack H Mendelson, et al.
The American Journal of Drug and Alcohol Abuse|March 7, 2023
Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorderKevin A Hallgren, Gantt P Galloway, Katie Witkiewitz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2003
Altering cortisol level does not change the pleasurable effects of methamphetamine in humansDebra S Harris, Victor I Reus, Owen M Wolkowitz, et al.
BMC Clinical Pharmacology|August 4, 2009
A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusionDebra S Harris, Thomas Everhart, Peyton Jacob, et al.
Clinical Pharmacokinetics|April 15, 2004
Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionalityDebra S Harris, John E Mendelson, Emil T Lin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 26, 2005
Repeated psychological stress testing in stimulant-dependent patientsDebra S Harris, Victor I Reus, Owen M Wolkowitz, et al.
Clinical Pharmacology and Therapeutics|October 31, 2003
The bioavailability of intranasal and smoked methamphetamineDebra S Harris, Harold Boxenbaum, E Thomas Everhart, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Biological Psychiatry|October 5, 2011
Is brain-derived neurotrophic factor a selective biomarker that predicts cocaine relapse outcomes?Jacqueline F McGinty, John E Mendelson
Nitric Oxide : Biology and Chemistry|July 13, 2007
Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction?Anousheh Kielstein, Dimitrios Tsikas, Gantt P Galloway, et al.
Journal of Addiction Medicine|August 17, 2011
A simple, novel method for assessing medication adherence: capsule photographs taken with cellular telephonesGantt P Galloway, Jeremy R Coyle, José Enrique Guillén, et al.
Psychopharmacology|August 13, 2002
Subjective and hormonal effects of 3,4-methylenedioxymethamphetamine (MDMA) in humansDebra S Harris, Matthew Baggott, Jack H Mendelson, et al.
The American Journal of Drug and Alcohol Abuse|March 7, 2023
Treatment retention and reductions in blood alcohol concentration (BAC) during the first 90 days of a telehealth program for alcohol use disorderKevin A Hallgren, Gantt P Galloway, Katie Witkiewitz, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 19, 2003
Altering cortisol level does not change the pleasurable effects of methamphetamine in humansDebra S Harris, Victor I Reus, Owen M Wolkowitz, et al.
BMC Clinical Pharmacology|August 4, 2009
A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusionDebra S Harris, Thomas Everhart, Peyton Jacob, et al.
Clinical Pharmacokinetics|April 15, 2004
Pharmacokinetics and subjective effects of sublingual buprenorphine, alone or in combination with naloxone: lack of dose proportionalityDebra S Harris, John E Mendelson, Emil T Lin, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 26, 2005
Repeated psychological stress testing in stimulant-dependent patientsDebra S Harris, Victor I Reus, Owen M Wolkowitz, et al.
Clinical Pharmacology and Therapeutics|October 31, 2003
The bioavailability of intranasal and smoked methamphetamineDebra S Harris, Harold Boxenbaum, E Thomas Everhart, et al.
Pageof 2